Keurig Dr Pepper Reports Strong Third Quarter Results
Keurig Dr Pepper (NASDAQ: KDP) reported a strong Q3 2020, with net sales rising 5.2% to $3.02 billion and diluted EPS increasing to $0.31 from $0.21 year-over-year. Adjusted diluted EPS grew 22% to $0.39. Key growth drivers included a 6.6% volume/mix increase and continued market share expansion across beverages. Operating income surged 29.8% to $753 million. The company anticipates finishing 2020 at the high end of its guidance, projecting net sales growth of 3-4% and adjusted EPS growth of 13-15% while reducing its leverage ratio. COVID-19 impact included $49 million in related costs.
- Net sales increased 5.2% to $3.02 billion.
- Diluted EPS rose to $0.31, up from $0.21.
- Adjusted diluted EPS grew 22% to $0.39.
- Operating income increased 29.8% to $753 million.
- Strong cash flow of $525 million, reducing debt by $225 million.
- Market share expanded in over 90% of liquid refreshment retail channels.
- COVID-19 related operating costs totaled $49 million.
- Beverage Concentrates segment net sales decreased 2.2%.
BURLINGTON, Mass. and PLANO, Texas, Oct. 29, 2020 /PRNewswire/ -- Keurig Dr Pepper Inc. (NASDAQ: KDP) today reported strong financial results for the third quarter ended September 30, 2020 and strengthened guidance for the full year.
On a GAAP basis, net sales in the third quarter of 2020 increased
Commenting on the announcement, Chairman and CEO Bob Gamgort stated, "Since the beginning of the pandemic, our broad beverage portfolio, unique route to market capabilities and resilient and dedicated team members have enabled KDP to successfully navigate through the challenging and volatile operating environment. In Q3, we delivered another strong quarter, marked by accelerated growth in net sales, adjusted operating income and EPS, while continuing to post strong market share growth across our portfolio and reducing our management leverage ratio. As a result, we're confident in our ability to deliver 2020 at the high-end of our guidance, while reinvesting any upside performance in brand marketing and innovation."
Third Quarter Consolidated Results
Net sales for the third quarter of 2020 increased
- Coffee Systems: Double-digit dollar growth in K-Cup coffee pods for at-home consumption was partially offset by weakness in the office coffee channel, as elevated work-from-home trends persisted throughout the quarter. Keurig brewers posted exceptional growth, driven by successful innovation and retailer inventory stocking ahead of the holiday season.
- Packaged Beverages: Broad-based market share expansion drove net sales in the majority of the segment's portfolio. Growth in large-format channels continued to be strong, and performance in the convenience and gas channels improved sequentially during the quarter, as consumer mobility increased.
- Beverage Concentrates: Performance improved significantly from the previous quarter, declining slightly versus the prior year, reflecting a sequential reopening of quick-serve and other fast-casual restaurants, which are serviced by the fountain foodservice component of the business.
- Latin America Beverages: Modest constant currency growth reflected sequential improvements in consumer mobility in Mexico.
KDP in-market performance2 in tracked channels for the third quarter of 2020 continued to be very strong, with market share advancing in more than
GAAP operating income increased
The COVID-19 related operating costs incurred in the third quarter of 2020 totaled
GAAP net income in the third quarter of 2020 increased
The Company generated strong free cash flow totaling
______________________________
1 Adjusted financial metrics used in this release are non-GAAP. See reconciliations of GAAP results to Adjusted results in the accompanying tables.
2 In-market performance (retail consumption; market share) based on Keurig Dr Pepper's custom IRi category definitions.
3 CSD refers to "Carbonated Soft Drink".
Third Quarter Segment Results
Coffee Systems
Net sales for the third quarter of 2020 increased
The volume/mix increase of
Operating income increased
Packaged Beverages
Net sales for the third quarter of 2020 advanced
Driving the net sales performance in the quarter were Dr Pepper, including the recently launched Dr Pepper & Cream Soda, and Canada Dry, including the recently launched Canada Dry Bold. Also contributing to the net sales growth were A&W, Snapple, Motts, 7UP, CORE, Sunkist, Squirt, Clamato, Real Lemon and mixers, partially offset by a decline in Bai.
Operating income increased
Beverage Concentrates
Net sales for the third quarter of 2020 decreased
The volume/mix performance, while still negatively impacted by COVID-19, improved significantly on a sequential basis in the quarter, reflecting a modest reopening of quick-serve and other fast-casual restaurants.
Total shipment volume versus year-ago declined
Operating income increased
Latin America Beverages
Net sales for the third quarter of 2020 decreased
Operating income of
KDP Outlook for 2020
KDP net sales and Adjusted diluted EPS growth for the first nine months of 2020 were
KDP Investor Contacts:
Tyson Seely
T: 781-418-3352 / tyson.seely@kdrp.com
Steve Alexander
T: 972-673-6769 / steve.alexander@kdrp.com
KDP Media Contact:
Katie Gilroy
T: 781-418-3345 / katie.gilroy@kdrp.com
About Keurig Dr Pepper
Keurig Dr Pepper (KDP) is a leading beverage company in North America, with annual revenue in excess of
FORWARD LOOKING STATEMENTS
Certain statements contained herein are "forward-looking statements" within the meaning of applicable securities laws and regulations. These forward-looking statements can generally be identified by the use of words such as "outlook," "guidance," "anticipate," "expect," "believe," "could," "estimate," "feel," "forecast," "intend," "may," "plan," "potential," "project," "should," "target," "will," "would," and similar words, phrases or expressions and variations or negatives of these words, although not all forward-looking statements contain these identifying words. Forward-looking statements by their nature address matters that are, to different degrees, uncertain, such as statements regarding the estimated or anticipated future results of the combined company following the combination of Keurig Green Mountain, Inc. ("KGM") and Dr Pepper Snapple Group, Inc. ("DPS" and such combination, the "transaction"), the anticipated benefits of the transaction, including estimated synergies and cost savings, the long-term merger targets, and other statements that are not historical facts. These statements are based on the current expectations of our management and are not predictions of actual performance.
These forward-looking statements are subject to a number of risks and uncertainties regarding the company's business and the transaction and actual results may differ materially. These risks and uncertainties include, but are not limited to: (i) the impact the significant additional debt incurred in connection with the transaction may have on our ability to operate our business, (ii) risks relating to the integration of the KGM and DPS operations, products and employees into the combined company and assumption of certain potential liabilities of KGM and the possibility that the anticipated synergies and other benefits of the transaction, including cost savings, will not be realized or will not be realized within the expected timeframe, (iii) the impact of the global COVID-19 pandemic, and (iv) risks relating to the businesses and the industries in which our combined company operates. These risks and uncertainties, as well as other risks and uncertainties, are more fully discussed in the Company's filings with the SEC, including our Annual Report on Form 10-K and subsequent filings. While the lists of risk factors presented here and in our public filings are considered representative, no such list should be considered to be a complete statement of all potential risks and uncertainties. Any forward-looking statement made herein speaks only as of the date of this document. We are under no obligation to, and expressly disclaim any obligation to, update or alter any forward-looking statements, whether as a result of new information, subsequent events or otherwise, except as required by applicable laws or regulations.
NON-GAAP FINANCIAL MEASURES
This release includes certain non-GAAP financial measures including Adjusted operating income, Adjusted net income, Adjusted diluted EPS and Free Cash Flow, which differ from results using U.S. Generally Accepted Accounting Principles (GAAP). These non-GAAP financial measures should be considered as supplements to the GAAP reported measures, should not be considered replacements for, or superior to, the GAAP measures and may not be comparable to similarly named measures used by other companies. Non-GAAP financial measures typically exclude certain charges, including one-time costs related to the transaction and integration activities, which are not expected to occur routinely in future periods. The Company uses non-GAAP financial measures internally to focus management on performance excluding these special charges to gauge our business operating performance. Management believes this information is helpful to investors because it increases transparency and assists investors in understanding the underlying performance of the Company and in the analysis of ongoing operating trends. Additionally, management believes that non-GAAP financial measures are frequently used by analysts and investors in their evaluation of companies, and continued inclusion provides consistency in financial reporting and enables analysts and investors to perform meaningful comparisons of past, present and future operating results. The most directly comparable GAAP financial measures and reconciliations to non-GAAP financial measures are set forth in the appendix to this release and included in the Company's filings with the SEC.
To the extent that the Company provides guidance, it does so only on a non-GAAP basis and does not provide reconciliations of such forward-looking non-GAAP measures to GAAP due to the inability to predict the amount and timing of impacts outside of the Company's control on certain items, such as non-cash gains or losses resulting from mark-to-market adjustments of derivative instruments, among others.
KEURIG DR PEPPER INC. | |||||||||||||||
Third Quarter | First Nine Months | ||||||||||||||
(in millions, except per share data) | 2020 | 2019 | 2020 | 2019 | |||||||||||
Net sales | $ | 3,020 | $ | 2,870 | $ | 8,497 | $ | 8,186 | |||||||
Cost of sales | 1,316 | 1,245 | 3,779 | 3,537 | |||||||||||
Gross profit | 1,704 | 1,625 | 4,718 | 4,649 | |||||||||||
Selling, general and administrative expenses | 949 | 1,012 | 2,978 | 2,951 | |||||||||||
Other operating expense (income), net | 2 | 33 | (40) | 33 | |||||||||||
Income from operations | 753 | 580 | 1,780 | 1,665 | |||||||||||
Interest expense | 148 | 158 | 458 | 497 | |||||||||||
Loss on early extinguishment of debt | — | — | 4 | 9 | |||||||||||
Impairment on investments and note receivable | 16 | — | 102 | — | |||||||||||
Other expense, net | 5 | 9 | 21 | 15 | |||||||||||
Income before provision for income taxes | 584 | 413 | 1,195 | 1,144 | |||||||||||
Provision for income taxes | 141 | 109 | 298 | 296 | |||||||||||
Net income | $ | 443 | $ | 304 | $ | 897 | $ | 848 | |||||||
Less: Net income attributable to non-controlling interest | — | — | — | — | |||||||||||
Net income attributable to KDP | $ | 443 | $ | 304 | $ | 897 | $ | 848 | |||||||
Earnings per common share: | |||||||||||||||
Basic | $ | 0.31 | $ | 0.22 | $ | 0.64 | $ | 0.60 | |||||||
Diluted | 0.31 | 0.21 | 0.63 | 0.60 | |||||||||||
Weighted average common shares outstanding: | |||||||||||||||
Basic | 1,407.3 | 1,406.8 | 1,407.2 | 1,406.6 | |||||||||||
Diluted | 1,422.9 | 1,419.4 | 1,421.5 | 1,418.8 |
KEURIG DR PEPPER INC. | |||||||
September 30, | December 31, | ||||||
(in millions, except share and per share data) | 2020 | 2019 | |||||
Assets | |||||||
Current assets: | |||||||
Cash and cash equivalents | $ | 191 | $ | 75 | |||
Restricted cash and restricted cash equivalents | 27 | 26 | |||||
Trade accounts receivable, net | 1,051 | 1,115 | |||||
Inventories | 824 | 654 | |||||
Prepaid expenses and other current assets | 323 | 403 | |||||
Total current assets | 2,416 | 2,273 | |||||
Property, plant and equipment, net | 2,092 | 2,028 | |||||
Investments in unconsolidated affiliates | 90 | 151 | |||||
Goodwill | 20,029 | 20,172 | |||||
Other intangible assets, net | 23,834 | 24,117 | |||||
Other non-current assets | 889 | 748 | |||||
Deferred tax assets | 31 | 29 | |||||
Total assets | $ | 49,381 | $ | 49,518 | |||
Liabilities and Stockholders' Equity | |||||||
Current liabilities: | |||||||
Accounts payable | $ | 3,517 | $ | 3,176 | |||
Accrued expenses | 1,067 | 939 | |||||
Structured payables | 160 | 321 | |||||
Short-term borrowings and current portion of long-term obligations | 2,182 | 1,593 | |||||
Other current liabilities | 403 | 445 | |||||
Total current liabilities | 7,329 | 6,474 | |||||
Long-term obligations | 11,707 | 12,827 | |||||
Deferred tax liabilities | 5,945 | 6,030 | |||||
Other non-current liabilities | 1,103 | 930 | |||||
Total liabilities | 26,084 | 26,261 | |||||
Commitments and contingencies | |||||||
Stockholders' equity: | |||||||
Preferred stock, | — | — | |||||
Common stock, | 14 | 14 | |||||
Additional paid-in capital | 21,654 | 21,557 | |||||
Retained earnings | 1,845 | 1,582 | |||||
Accumulated other comprehensive (income) loss | (217) | 104 | |||||
Total equity | 23,296 | 23,257 | |||||
Non-controlling interest | 1 | — | |||||
Total stockholders' equity | 23,297 | 23,257 | |||||
Total liabilities and stockholders' equity | $ | 49,381 | $ | 49,518 |
KEURIG DR PEPPER INC. | |||||||
First Nine Months | |||||||
(in millions) | 2020 | 2019 | |||||
Operating activities: | |||||||
Net income | $ | 897 | $ | 848 | |||
Adjustments to reconcile net income to net cash provided by operating activities: | |||||||
Depreciation expense | 272 | 271 | |||||
Amortization of intangibles | 100 | 94 | |||||
Other amortization expense | 118 | 135 | |||||
Provision for sales returns | 36 | 25 | |||||
Deferred income taxes | (27) | (5) | |||||
Employee stock-based compensation expense | 62 | 47 | |||||
Loss on early extinguishment of debt | 4 | 9 | |||||
(Gain) loss on disposal of property, plant and equipment | (39) | 11 | |||||
Unrealized loss (gain) on foreign currency | 14 | (22) | |||||
Unrealized loss on derivatives | 47 | 60 | |||||
Equity in loss of unconsolidated affiliates | 19 | 38 | |||||
Impairment on investments and note receivable of unconsolidated affiliate | 102 | — | |||||
Other, net | 50 | 33 | |||||
Changes in assets and liabilities: | |||||||
Trade accounts receivable | (1) | 36 | |||||
Inventories | (175) | (124) | |||||
Income taxes receivable and payables, net | (118) | (9) | |||||
Other current and non-current assets | (387) | (156) | |||||
Accounts payable and accrued expenses | 500 | 561 | |||||
Other current and non-current liabilities | 192 | (49) | |||||
Net change in operating assets and liabilities | 11 | 259 | |||||
Net cash provided by operating activities | 1,666 | 1,803 | |||||
Investing activities: | |||||||
Acquisitions of businesses | — | (8) | |||||
Issuance of related party note receivable | (6) | (22) | |||||
Investments in unconsolidated affiliates | (4) | (16) | |||||
Purchases of property, plant and equipment | (356) | (208) | |||||
Proceeds from sales of property, plant and equipment | 203 | 19 | |||||
Purchases of intangibles | (26) | (4) | |||||
Other, net | 7 | 23 | |||||
Net cash used in investing activities | (182) | (216) | |||||
Financing activities: | |||||||
Proceeds from controlling shareholder stock transactions | 29 | — | |||||
Proceeds from unsecured credit facility | 1,850 | — | |||||
Proceeds from senior unsecured notes | 1,500 | — | |||||
Proceeds from term loan | — | 2,000 | |||||
Net (payment) issuance of commercial paper | (911) | 335 | |||||
Proceeds from structured payables | 128 | 246 | |||||
Payments on structured payables | (290) | (432) | |||||
Payments on senior unsecured notes | (250) | (250) | |||||
Payment on unsecured credit facility | (1,850) | — | |||||
Payments on term loan | (880) | (2,873) | |||||
Payments on finance leases | (35) | (29) | |||||
Cash dividends paid | (635) | (633) | |||||
Other, net | (22) | 10 | |||||
Net cash used in financing activities | (1,366) | (1,626) | |||||
Cash, cash equivalents, restricted cash and restricted cash equivalents — net change from: | |||||||
Operating, investing and financing activities | 118 | (39) | |||||
Effect of exchange rate changes on cash, cash equivalents, restricted cash and restricted cash equivalents | (11) | 12 | |||||
Cash, cash equivalents, restricted cash and restricted cash equivalents at beginning of period | 111 | 139 | |||||
Cash, cash equivalents, restricted cash and restricted cash equivalents at end of period | $ | 218 | $ | 112 |
KEURIG DR PEPPER INC. | |||||||||||||||
Third Quarter | First Nine Months | ||||||||||||||
(in millions) | 2020 | 2019 | 2020 | 2019 | |||||||||||
Net Sales | |||||||||||||||
Coffee Systems | $ | 1,097 | $ | 1,065 | $ | 3,113 | $ | 3,023 | |||||||
Packaged Beverages | 1,447 | 1,307 | 4,056 | 3,734 | |||||||||||
Beverage Concentrates | 352 | 360 | 967 | 1,034 | |||||||||||
Latin America Beverages | 124 | 138 | 361 | 395 | |||||||||||
Total net sales | $ | 3,020 | $ | 2,870 | $ | 8,497 | $ | 8,186 | |||||||
Income from Operations | |||||||||||||||
Coffee Systems | $ | 320 | $ | 310 | $ | 882 | $ | 890 | |||||||
Packaged Beverages | 260 | 196 | 657 | 531 | |||||||||||
Beverage Concentrates | 262 | 245 | 679 | 690 | |||||||||||
Latin America Beverages | 25 | 25 | 73 | 62 | |||||||||||
Unallocated corporate costs | (114) | (196) | (511) | (508) | |||||||||||
Total income from operations | $ | 753 | $ | 580 | $ | 1,780 | $ | 1,665 |
KEURIG DR PEPPER INC.
RECONCILIATION OF CERTAIN NON-GAAP INFORMATION
(Unaudited)
The company reports its financial results in accordance with U.S. GAAP. However, management believes that certain non-GAAP financial measures that reflect the way management evaluates the business may provide investors with additional information regarding the company's results, trends and ongoing performance on a comparable basis.
For the third quarter and first nine months of 2020 and 2019, we define our Adjusted non-GAAP financial measures as certain financial statement captions and metrics adjusted for certain items affecting comparability. The items affecting comparability are defined below.
Specifically, investors should consider the following with respect to our financial results:
Adjusted: Defined as certain financial statement captions and metrics adjusted for certain items affecting comparability.
Items affecting comparability: Defined as certain items that are excluded for comparison to prior year periods, adjusted for the tax impact as applicable. Tax impact is determined based upon an approximate rate for each item. For each period, management adjusts for (i) the unrealized mark-to-market impact of derivative instruments not designated as hedges in accordance with U.S. GAAP and do not have an offsetting risk reflected within the financial results; (ii) the amortization associated with definite-lived intangible assets; (iii) the amortization of the deferred financing costs associated with the DPS Merger and Keurig Acquisition; (iv) the amortization of the fair value adjustment of the senior unsecured notes obtained as a result of the DPS Merger; (v) stock compensation expense attributable to the matching awards made to employees who made an initial investment in the Keurig Green Mountain, Inc. Executive Ownership Plan, the Keurig Dr Pepper Omnibus Incentive Plan of 2009 or the Keurig Dr Pepper Inc. Omnibus Incentive Plan of 2019; and (vi) other certain items that are excluded for comparison purposes to prior year periods.
For third quarter and first nine months of 2020, the other certain items excluded for comparison purposes include (i) restructuring and integration expenses related to significant business combinations; (ii) productivity expenses; (iii) costs related to significant nonroutine legal matters; (iv) the loss on early extinguishment of debt related to the redemption of debt; (v) incremental temporary costs to our operations related to risks associated with the COVID-19 pandemic and (vi) impairment recognized on equity method investments with Bedford Systems, LLC and LifeFuels Inc.
Incremental costs to our operations related to risks associated with the COVID-19 pandemic include incremental expenses incurred to either maintain the health and safety of our front-line employees or temporarily increase compensation to such employees to ensure essential operations continue during the pandemic. We believe removing these costs reflects how management views our business results on a consistent basis.
For third quarter and first nine months of 2019, the other certain items excluded for comparison purposes include (i) restructuring and integration expenses related to significant business combinations; (ii) productivity expenses; (iii) transaction costs for significant business combinations (completed or abandoned) excluding the DPS Merger; (iv) costs related to significant nonroutine legal matters; (v) the impact of the step-up of acquired inventory not associated with the DPS Merger (vi) the loss on early extinguishment of debt related to the redemption of debt and (vii) the loss related to the February 2019 organized malware attack on our business operation networks in the Coffee Systems segment.
For the third quarter and first nine months of 2020 and 2019, the supplemental financial data set forth below includes reconciliations of Adjusted income from operations, Adjusted net income and Adjusted diluted EPS to the applicable financial measure presented in the unaudited condensed consolidated financial statement for the same period.
Reconciliations for these items are provided in the tables below.
KEURIG DR PEPPER INC. | ||||||||||||||||||||||||||||
Cost of sales | Gross profit | Gross margin | Selling, general | Income from operations | Operating margin | |||||||||||||||||||||||
Reported | $ | 1,316 | $ | 1,704 | 56.4 | % | $ | 949 | $ | 753 | 24.9 | % | ||||||||||||||||
Items Affecting Comparability: | ||||||||||||||||||||||||||||
Mark to market | 46 | (46) | (1) | (45) | ||||||||||||||||||||||||
Amortization of intangibles | — | — | (34) | 34 | ||||||||||||||||||||||||
Stock compensation | — | — | (6) | 6 | ||||||||||||||||||||||||
Restructuring and integration costs | — | — | (39) | 39 | ||||||||||||||||||||||||
Productivity | (10) | 10 | (20) | 30 | ||||||||||||||||||||||||
Nonroutine legal matters | — | — | (8) | 8 | ||||||||||||||||||||||||
COVID-19 | (19) | 19 | (30) | 49 | ||||||||||||||||||||||||
Adjusted GAAP | $ | 1,333 | $ | 1,687 | 55.9 | % | $ | 811 | $ | 874 | 28.9 | % | ||||||||||||||||
Interest expense | Impairment on | Income | Provision | Effective tax rate | Net income | Weighted Average Diluted shares | Diluted | |||||||||||||||||||||
Reported | $ | 148 | $ | 16 | $ | 584 | $ | 141 | 24.1 | % | $ | 443 | 1,422.9 | $ | 0.31 | |||||||||||||
Items Affecting Comparability: | ||||||||||||||||||||||||||||
Mark to market | (1) | — | (44) | (13) | (31) | (0.02) | ||||||||||||||||||||||
Amortization of intangibles | — | — | 34 | 9 | 25 | 0.02 | ||||||||||||||||||||||
Amortization of deferred financing costs | (2) | — | 2 | 1 | 1 | — | ||||||||||||||||||||||
Amortization of fair value debt adjustment | (6) | — | 6 | 1 | 5 | — | ||||||||||||||||||||||
Stock compensation | — | — | 6 | 1 | 5 | — | ||||||||||||||||||||||
Restructuring and integration costs | — | — | 39 | 8 | 31 | 0.02 | ||||||||||||||||||||||
Productivity | — | — | 30 | 8 | 22 | 0.02 | ||||||||||||||||||||||
Investment Impairment | — | (16) | 16 | 4 | 12 | 0.01 | ||||||||||||||||||||||
Nonroutine legal matters | — | — | 8 | 1 | 7 | — | ||||||||||||||||||||||
COVID-19 | — | — | 49 | 12 | 37 | 0.03 | ||||||||||||||||||||||
Adjusted GAAP | $ | 139 | $ | — | $ | 730 | $ | 173 | 23.7 | % | $ | 557 | 1,422.9 | $ | 0.39 |
Diluted earnings per common share may not foot due to rounding. |
KEURIG DR PEPPER INC. | |||||||||||||||||||||||||
Cost of sales | Gross profit | Gross margin | Selling, general and | Other | Income | Operating margin | |||||||||||||||||||
Reported | $ | 1,245 | $ | 1,625 | 56.6 | % | $ | 1,012 | $ | 33 | $ | 580 | 20.2 | % | |||||||||||
Items Affecting Comparability: | |||||||||||||||||||||||||
Mark to market | (5) | 5 | (4) | — | 9 | ||||||||||||||||||||
Amortization of intangibles | — | — | (31) | — | 31 | ||||||||||||||||||||
Stock compensation | — | — | (3) | — | 3 | ||||||||||||||||||||
Restructuring and integration costs | 1 | (1) | (54) | (24) | 77 | ||||||||||||||||||||
Productivity | (10) | 10 | (12) | (13) | 35 | ||||||||||||||||||||
Transaction costs | — | — | (7) | — | 7 | ||||||||||||||||||||
Nonroutine legal matters | — | — | (12) | — | 12 | ||||||||||||||||||||
Adjusted GAAP | $ | 1,231 | $ | 1,639 | 57.1 | % | $ | 889 | $ | (4) | $ | 754 | 26.3 | % |
Interest expense | Income before | Provision for income taxes | Effective tax rate | Net income | Weighted | Diluted | ||||||||||||||||||
Reported | $ | 158 | $ | 413 | $ | 109 | 26.4 | % | $ | 304 | 1,419.4 | $ | 0.21 | |||||||||||
Items Affecting Comparability: | ||||||||||||||||||||||||
Mark to market | 1 | 8 | — | 8 | 0.01 | |||||||||||||||||||
Amortization of intangibles | — | 31 | 9 | 22 | 0.02 | |||||||||||||||||||
Amortization of deferred financing costs | (3) | 3 | 1 | 2 | — | |||||||||||||||||||
Amortization of fair value debt adjustment | (7) | 7 | 3 | 4 | — | |||||||||||||||||||
Stock compensation | — | 3 | — | 3 | — | |||||||||||||||||||
Restructuring and integration costs | — | 77 | 13 | 64 | 0.04 | |||||||||||||||||||
Productivity | — | 35 | 8 | 27 | 0.02 | |||||||||||||||||||
Transaction costs | (4) | 11 | 3 | 8 | 0.01 | |||||||||||||||||||
Nonroutine legal matters | — | 12 | 3 | 9 | 0.01 | |||||||||||||||||||
Adjusted GAAP | $ | 145 | $ | 600 | $ | 149 | 24.8 | % | $ | 451 | 1,419.4 | $ | 0.32 |
Numbers may not foot due to rounding. |
KEURIG DR PEPPER INC. | |||||||||||||||||||||
Cost of sales | Gross profit | Gross margin | Selling, general administrative | Income from operations | Operating margin | ||||||||||||||||
Reported | $ | 3,779 | $ | 4,718 | 55.5 | % | $ | 2,978 | $ | 1,780 | 20.9 | % | |||||||||
Items Affecting Comparability: | |||||||||||||||||||||
Mark to market | 2 | (2) | (28) | 26 | |||||||||||||||||
Amortization of intangibles | — | — | (100) | 100 | |||||||||||||||||
Stock compensation | — | — | (21) | 21 | |||||||||||||||||
Restructuring and integration costs | — | — | (143) | 143 | |||||||||||||||||
Productivity | (28) | 28 | (75) | 103 | |||||||||||||||||
Nonroutine legal matters | — | — | (43) | 43 | |||||||||||||||||
COVID-19 | (38) | 38 | (79) | 117 | |||||||||||||||||
Adjusted GAAP | $ | 3,715 | $ | 4,782 | 56.3 | % | $ | 2,489 | $ | 2,333 | 27.5 | % |
Interest expense | Loss on early extinguishment of debt | Impairment on and note | Income before | Provision for income taxes | Effective tax rate | Net income | Weighted Average Diluted shares | Diluted earnings per share | ||||||||||||||||||||||||
Reported | $ | 458 | $ | 4 | $ | 102 | $ | 1,195 | $ | 298 | 24.9 | % | $ | 897 | 1,421.5 | $ | 0.63 | |||||||||||||||
Items Affecting Comparability: | ||||||||||||||||||||||||||||||||
Mark to market | (28) | — | — | 54 | 13 | 41 | 0.03 | |||||||||||||||||||||||||
Amortization of intangibles | — | — | — | 100 | 27 | 73 | 0.05 | |||||||||||||||||||||||||
Amortization of deferred financing costs | (8) | — | — | 8 | 2 | 6 | — | |||||||||||||||||||||||||
Amortization of fair value debt adjustment | (18) | — | — | 18 | 4 | 14 | 0.01 | |||||||||||||||||||||||||
Stock compensation | — | — | — | 21 | 4 | 17 | 0.01 | |||||||||||||||||||||||||
Restructuring and integration costs | — | — | — | 143 | 34 | 109 | 0.08 | |||||||||||||||||||||||||
Productivity | — | — | — | 103 | 27 | 76 | 0.05 | |||||||||||||||||||||||||
Loss on early extinguishment of debt | — | (4) | — | 4 | 1 | 3 | — | |||||||||||||||||||||||||
Impairment on investment | — | — | (102) | 102 | 25 | 77 | 0.05 | |||||||||||||||||||||||||
Nonroutine legal matters | — | — | — | 43 | 10 | 33 | 0.02 | |||||||||||||||||||||||||
COVID-19 | — | — | — | 117 | 29 | 88 | 0.06 | |||||||||||||||||||||||||
Adjusted GAAP | $ | 404 | $ | — | $ | — | $ | 1,908 | $ | 474 | 24.8 | % | $ | 1,434 | 1,421.5 | $ | 1.01 |
Diluted earnings per common share may not foot due to rounding. |
KEURIG DR PEPPER INC. | |||||||||||||||||||||||||
Cost of sales | Gross profit | Gross margin | Selling, general and | Other operating | Income from operations | Operating margin | |||||||||||||||||||
Reported | $ | 3,537 | $ | 4,649 | 56.8 | % | $ | 2,951 | $ | 33 | $ | 1,665 | 20.3 | % | |||||||||||
Items Affecting Comparability: | |||||||||||||||||||||||||
Mark to market | (6) | 6 | 5 | — | 1 | ||||||||||||||||||||
Amortization of intangibles | — | — | (94) | — | 94 | ||||||||||||||||||||
Stock compensation | — | — | (18) | — | 18 | ||||||||||||||||||||
Restructuring and integration costs | (1) | 1 | (151) | (24) | 176 | ||||||||||||||||||||
Productivity | (14) | 14 | (41) | (22) | 77 | ||||||||||||||||||||
Transaction costs | — | — | (8) | — | 8 | ||||||||||||||||||||
Nonroutine legal matters | — | — | (27) | — | 27 | ||||||||||||||||||||
Inventory step-up | (3) | 3 | — | — | 3 | ||||||||||||||||||||
Malware incident | (2) | 2 | (6) | — | 8 | ||||||||||||||||||||
Adjusted GAAP | $ | 3,511 | $ | 4,675 | 57.1 | % | $ | 2,611 | $ | (13) | $ | 2,077 | 25.4 | % |
Interest expense | Loss on early extinguishment of debt | Income before | Provision | Effective tax rate | Net income | Weighted Average Diluted shares | Diluted earnings per share | |||||||||||||||||||||
Reported | $ | 497 | $ | 9 | $ | 1,144 | $ | 296 | 25.9 | % | $ | 848 | 1,418.8 | $ | 0.60 | |||||||||||||
Items Affecting Comparability: | ||||||||||||||||||||||||||||
Mark to market | (44) | — | 45 | 11 | 34 | 0.02 | ||||||||||||||||||||||
Amortization of intangibles | — | — | 94 | 26 | 68 | 0.05 | ||||||||||||||||||||||
Amortization of deferred financing costs | (10) | — | 10 | 3 | 7 | 0.01 | ||||||||||||||||||||||
Amortization of fair value debt adjustment | (20) | — | 20 | 5 | 15 | 0.01 | ||||||||||||||||||||||
Stock compensation | — | — | 18 | 4 | 14 | 0.01 | ||||||||||||||||||||||
Restructuring and integration costs | — | — | 176 | 39 | 137 | 0.10 | ||||||||||||||||||||||
Productivity | — | — | 77 | 17 | 60 | 0.04 | ||||||||||||||||||||||
Transaction costs | (16) | — | 24 | 6 | 18 | 0.01 | ||||||||||||||||||||||
Loss on early extinguishment of debt | — | (9) | 9 | 2 | 7 | — | ||||||||||||||||||||||
Nonroutine legal matters | — | — | 27 | 7 | 20 | 0.01 | ||||||||||||||||||||||
Inventory step-up | — | — | 3 | 1 | 2 | — | ||||||||||||||||||||||
Malware incident | — | — | 8 | 2 | 6 | — | ||||||||||||||||||||||
Adjusted GAAP | $ | 407 | $ | — | $ | 1,655 | $ | 419 | 25.3 | % | $ | 1,236 | 1,418.8 | $ | 0.87 |
Diluted earnings per common share may not foot due to rounding. |
KEURIG DR PEPPER INC. | |||||||||||
(in millions) | Reported | Items Affecting Comparability | Adjusted GAAP | ||||||||
For the third quarter of 2020: | |||||||||||
Income from Operations | |||||||||||
Coffee Systems | $ | 320 | $ | 53 | $ | 373 | |||||
Packaged Beverages | 260 | 44 | 304 | ||||||||
Beverage Concentrates | 262 | 3 | 265 | ||||||||
Latin America Beverages | 25 | — | 25 | ||||||||
Unallocated corporate costs | (114) | 21 | (93) | ||||||||
Total income from operations | $ | 753 | $ | 121 | $ | 874 | |||||
For the third quarter of 2019: | |||||||||||
Income from Operations | |||||||||||
Coffee Systems | $ | 310 | $ | 57 | $ | 367 | |||||
Packaged Beverages | 196 | 5 | 201 | ||||||||
Beverage Concentrates | 245 | (1) | 244 | ||||||||
Latin America Beverages | 25 | — | 25 | ||||||||
Unallocated corporate costs | (196) | 113 | (83) | ||||||||
Total income from operations | $ | 580 | $ | 174 | $ | 754 |
Numbers may not foot due to rounding. |
KEURIG DR PEPPER INC. | |||||||||||
(in millions) | Reported | Items Affecting Comparability | Adjusted GAAP | ||||||||
For the first nine months of 2020: | |||||||||||
Income from Operations | |||||||||||
Coffee Systems | $ | 882 | $ | 201 | $ | 1,083 | |||||
Packaged Beverages | 657 | 119 | 776 | ||||||||
Beverage Concentrates | 679 | 5 | 684 | ||||||||
Latin America Beverages | 73 | 2 | 75 | ||||||||
Unallocated corporate costs | (511) | 226 | (285) | ||||||||
Total income from operations | $ | 1,780 | $ | 553 | $ | 2,333 | |||||
For the first nine months of 2019: | |||||||||||
Income from Operations | |||||||||||
Coffee Systems | $ | 890 | $ | 143 | $ | 1,033 | |||||
Packaged Beverages | 531 | 20 | 551 | ||||||||
Beverage Concentrates | 690 | 1 | 691 | ||||||||
Latin America Beverages | 62 | (5) | 57 | ||||||||
Unallocated corporate costs | (508) | 253 | (255) | ||||||||
Total income from operations | $ | 1,665 | $ | 412 | $ | 2,077 |
KEURIG DR PEPPER INC. | |||
(in millions, except for ratio) | |||
ADJUSTED EBITDA RECONCILIATION - LAST TWELVE MONTHS | |||
Net income | $ | 1,303 | |
Interest expense | 615 | ||
Provision for income taxes | 442 | ||
Loss on early extinguishment of debt | 6 | ||
Impairment on investment | 102 | ||
Other (income) expense, net | 25 | ||
Depreciation expense | 359 | ||
Other amortization | 156 | ||
Amortization of intangibles | 132 | ||
EBITDA | $ | 3,140 | |
Items affecting comparability: | |||
Restructuring and integration expenses | $ | 205 | |
Transaction costs | 1 | ||
Productivity | 106 | ||
Nonroutine legal matters | 64 | ||
Stock compensation | 27 | ||
Mark to market | (20) | ||
COVID-19 | 117 | ||
Adjusted EBITDA | $ | 3,640 | |
September 30, | |||
2020 | |||
Principal amounts of: | |||
Commercial paper notes | $ | 335 | |
Term loan | 500 | ||
Senior unsecured notes | 13,225 | ||
Total principal amounts | 14,060 | ||
Less: Cash and cash equivalents | 191 | ||
Total principal amounts less cash and cash equivalents | $ | 13,869 | |
September 30, 2020 Management Leverage Ratio | 3.8 |
KEURIG DR PEPPER INC. | |||||||||||
(in millions) | FOURTH QUARTER OF 2019 | FIRST NINE MONTHS OF 2020 | LAST TWELVE MONTHS | ||||||||
Net income | $ | 406 | $ | 897 | $ | 1,303 | |||||
Interest expense | 157 | 458 | 615 | ||||||||
Provision for income taxes | 144 | 298 | 442 | ||||||||
Loss on early extinguishment of debt | 2 | 4 | 6 | ||||||||
Impairment on investment | — | 102 | 102 | ||||||||
Other (income) expense, net | 4 | 21 | 25 | ||||||||
Depreciation expense | 87 | 272 | 359 | ||||||||
Other amortization(1) | 38 | 118 | 156 | ||||||||
Amortization of intangibles | 32 | 100 | 132 | ||||||||
EBITDA | $ | 870 | $ | 2,270 | $ | 3,140 | |||||
Items affecting comparability: | |||||||||||
Restructuring and integration expenses | $ | 62 | $ | 143 | $ | 205 | |||||
Transaction costs | 1 | — | 1 | ||||||||
Productivity | 20 | 86 | 106 | ||||||||
Nonroutine legal matters | 21 | 43 | 64 | ||||||||
Stock compensation | 6 | 21 | 27 | ||||||||
COVID-19 | — | 117 | 117 | ||||||||
Mark to market | (46) | 26 | (20) | ||||||||
Adjusted EBITDA | $ | 934 | $ | 2,706 | $ | 3,640 |
(1) Other amortization was added to the EBITDA calculation in the first quarter of 2020. |
KEURIG DR PEPPER INC.
RECONCILIATION OF NET CASH PROVIDED BY OPERATING ACTIVITIES TO FREE CASH FLOW
(Unaudited)
Free cash flow is defined as net cash provided by operating activities adjusted for purchases of property, plant and equipment, proceeds from sales of property, plant and equipment, and certain items excluded for comparison to prior year periods. For the first nine months of 2020 and 2019, there were no certain items excluded for comparison to prior year periods.
First Nine Months | ||||||||
(in millions) | 2020 | 2019 | ||||||
Net cash provided by operating activities | $ | 1,666 | $ | 1,803 | ||||
Purchases of property, plant and equipment | (356) | (208) | ||||||
Proceeds from sales of property, plant and equipment | 203 | 19 | ||||||
Free Cash Flow | $ | 1,513 | $ | 1,614 |
RECONCILIATION OF CERTAIN CURRENCY NEUTRAL ADJUSTED FINANCIAL RESULTS
(Unaudited)
Net sales, adjusted income from operations and adjusted earnings per share, as adjusted to currency neutral: These adjusted financial results are calculated on a currency neutral basis by converting our current-period local currency financial results using the prior-period foreign currency exchange rates.
For the Third Quarter of 2020 | |||||||||||||||
Coffee | Packaged | Beverage | Latin America | ||||||||||||
Percent change | Systems | Beverages | Concentrates | Beverages | Total | ||||||||||
Net sales | 3.0 | % | 10.7 | % | (2.2) | % | (10.1) | % | 5.2 | % | |||||
Impact of foreign currency | 0.2 | % | — | % | — | % | 10.8 | % | 0.6 | % | |||||
Net sales, as adjusted to currency neutral | 3.2 | % | 10.7 | % | (2.2) | % | 0.7 | % | 5.8 | % |
For the Third Quarter of 2020 | |||||||||||||||
Coffee | Packaged | Beverage | Latin America | ||||||||||||
Percent change | Systems | Beverages | Concentrates | Beverages | Total | ||||||||||
Adjusted income from operations | 1.6 | % | 51.2 | % | 8.6 | % | — | % | 15.9 | % | |||||
Impact of foreign currency | — | % | — | % | — | % | 12.0 | % | 0.4 | % | |||||
Adjusted income from operations, as adjusted to currency neutral | 1.6 | % | 51.2 | % | 8.6 | % | 12.0 | % | 16.3 | % |
For the First Nine Months of 2020 | |||||||||||||||
Coffee | Packaged | Beverage | Latin America | ||||||||||||
Percent change | Systems | Beverages | Concentrates | Beverages | Total | ||||||||||
Net sales | 3.0 | % | 8.6 | % | (6.5) | % | (8.6) | % | 3.8 | % | |||||
Impact of foreign currency | 0.1 | % | 0.1 | % | 0.1 | % | 10.9 | % | 0.6 | % | |||||
Net sales, as adjusted to currency neutral | 3.1 | % | 8.7 | % | (6.4) | % | 2.3 | % | 4.4 | % |
For the First Nine Months of 2020 | |||||||||||||||
Coffee | Packaged | Beverage | Latin America | ||||||||||||
Percent change | Systems | Beverages | Concentrates | Beverages | Total | ||||||||||
Adjusted income from operations | 4.8 | % | 40.8 | % | (1.0) | % | 31.6 | % | 12.3 | % | |||||
Impact of foreign currency | 0.1 | % | — | % | 0.1 | % | 14.0 | % | 0.5 | % | |||||
Adjusted income from operations, as adjusted to currency neutral | 4.9 | % | 40.8 | % | (0.9) | % | 45.6 | % | 12.8 | % |
For the Third Quarter of 2020 | For the First Nine Months of 2020 | |||||||
Adjusted diluted earnings per share | $ | 0.39 | $ | 1.01 | ||||
Impact of foreign currency | — | — | ||||||
Adjusted diluted earnings per share, as adjusted to currency neutral | $ | 0.39 | $ | 1.01 |
The following table sets forth our reconciliation of significant COVID-19-related expenses. However, employee compensation expense and employee protection costs, which impact our SG&A expenses and cost of sales, are included as the COVID-19 item affecting comparability and is excluded in our Adjusted financial measures. In addition, reported amounts under U.S. GAAP also include additional costs, not included as the COVID-19 item affecting comparability, as presented in tables below.
Items Effecting Comparability(1) | |||||||||||||||||||
(in millions) | Employee Compensation Expense(2) | Employee Protection Costs(3) | Allowances for Expected Credit Losses(4) | Inventory Write-Downs(5) | Total | ||||||||||||||
For the third quarter of 2020: | |||||||||||||||||||
Coffee Systems | $ | 7 | $ | 5 | $ | — | $ | — | $ | 12 | |||||||||
Packaged Beverages | 32 | 4 | — | — | 36 | ||||||||||||||
Beverage Concentrates | — | — | — | — | — | ||||||||||||||
Latin America Beverages | — | 1 | — | — | 1 | ||||||||||||||
Unallocated corporate costs | — | — | — | — | — | ||||||||||||||
Total | $ | 39 | $ | 10 | $ | — | $ | — | $ | 49 | |||||||||
For the first nine months of 2020: | |||||||||||||||||||
Coffee Systems | $ | 14 | $ | 7 | $ | 2 | $ | 8 | $ | 31 | |||||||||
Packaged Beverages | 73 | 22 | 8 | — | 103 | ||||||||||||||
Beverage Concentrates | — | — | 4 | — | 4 | ||||||||||||||
Latin America Beverages | — | 1 | — | — | 1 | ||||||||||||||
Unallocated corporate costs | — | — | — | — | — | ||||||||||||||
Total | $ | 87 | $ | 30 | $ | 14 | $ | 8 | $ | 139 | |||||||||
(1) | Employee compensation expense and employee protection costs are both included as the COVID-19 items affecting comparability in the reconciliation of our Adjusted Non-GAAP financial measures. |
(2) | Reflects temporary incremental frontline incentive pay and the associated taxes in order to maintain essential operations during the COVID-19 pandemic. Impacts both cost of sales and SG&A expenses. |
(3) | Includes costs associated with personal protective equipment, temperature scans, cleaning and other sanitization services. Impacts both cost of sales and SG&A expenses. |
(4) | Allowances reflect the expected impact of the economic uncertainty caused by COVID-19, leveraging estimates of credit worthiness, default and recovery rates for certain of our customers. Impacts SG&A expenses. |
(5) | Inventory write-downs include obsolescence charges of |
View original content to download multimedia:http://www.prnewswire.com/news-releases/keurig-dr-pepper-reports-strong-third-quarter-results-301162379.html
SOURCE Keurig Dr Pepper
FAQ
What were Keurig Dr Pepper's Q3 2020 financial results?
How did KDP perform in the beverage market during Q3 2020?
What is KDP's EPS growth forecast for 2020?
What were the main drivers of KDP's revenue growth in Q3 2020?
What impact did COVID-19 have on KDP's financials?